Cargando…
The EGF Domains of MUC4 Oncomucin Mediate HER2 Binding Affinity and Promote Pancreatic Cancer Cell Tumorigenesis
SIMPLE SUMMARY: A feature of pancreatic cancer (PC) is the frequent overexpression of tyrosine kinase membrane receptor HER2 along with its membrane partner the MUC4 oncomucin in the early stages of the pancreatic carcinogenesis. However, therapeutic approaches targeting HER2 in PC are not efficient...
Autores principales: | Stoup, Nicolas, Liberelle, Maxime, Schulz, Céline, Cavdarli, Sumeyye, Vasseur, Romain, Magnez, Romain, Lahdaoui, Fatima, Skrypek, Nicolas, Peretti, Fabien, Frénois, Frédéric, Thuru, Xavier, Melnyk, Patricia, Renault, Nicolas, Jonckheere, Nicolas, Lebègue, Nicolas, Van Seuningen, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616066/ https://www.ncbi.nlm.nih.gov/pubmed/34830899 http://dx.doi.org/10.3390/cancers13225746 |
Ejemplares similares
-
MUC4-ErbB2 Oncogenic Complex: Binding studies using Microscale Thermophoresis
por: Liberelle, Maxime, et al.
Publicado: (2019) -
Publisher Correction: MUC4-ErbB2 Oncogenic Complex: Binding studies using Microscale Thermophoresis
por: Liberelle, Maxime, et al.
Publicado: (2020) -
Antagonistic Roles of the Tumor Suppressor miR-210-3p and Oncomucin MUC4 Forming a Negative Feedback Loop in Pancreatic Adenocarcinoma
por: Boukrout, Nihad, et al.
Publicado: (2021) -
Targeting MUC4 in pancreatic cancer: miRNAs
por: Jonckheere, Nicolas, et al.
Publicado: (2015) -
The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2
por: Skrypek, Nicolas, et al.
Publicado: (2015)